Volume 204, Issue 6: 4 April 2016. Professor Paul Myles, Director of Anaesthesia and Perioperative Medicine at the Alfred and Monash University, and Sophie Wallace, research manager at Alfred Health, discuss the need to streamline the reporting of serious adverse events in Phase IV clinical trials. With MJA news and online editor, Cate Swannell.

свернуть